APEX1 and colorectal carcinoma: The authors suggest that the overexpression of Jagged1 by APEX1 could represent a predictor of response to chemotherapy and of poor prognosis, and the combined expression of both proteins could be a therapeutic target for chemotherapy of advanced CRC [209] (Figure 3).